P-ETHYLPHENOL
Relevant Data
Food Additives Approved by WHO:
Flavouring Substances Approved by European Union:
General Information
Mainterm | P-ETHYLPHENOL |
Doc Type | ASP |
CAS Reg.No.(or other ID) | 123-07-9 |
Regnum |
From www.fda.gov
Computed Descriptors
Download SDF2D Structure | |
CID | 31242 |
IUPAC Name | 4-ethylphenol |
InChI | InChI=1S/C8H10O/c1-2-7-3-5-8(9)6-4-7/h3-6,9H,2H2,1H3 |
InChI Key | HXDOZKJGKXYMEW-UHFFFAOYSA-N |
Canonical SMILES | CCC1=CC=C(C=C1)O |
Molecular Formula | C8H10O |
Wikipedia | 4-ethylphenol |
From Pubchem
Computed Properties
Property Name | Property Value |
---|---|
Molecular Weight | 122.167 |
Hydrogen Bond Donor Count | 1 |
Hydrogen Bond Acceptor Count | 1 |
Rotatable Bond Count | 1 |
Complexity | 72.6 |
CACTVS Substructure Key Fingerprint | A A A D c c B w I A A A A A A A A A A A A A A A A A A A A A A A A A A w A A A A A A A A A A A B A A A A G g A A C A A A D A S A m A A y B o A A A g C A A i B C A A A C A A A g I A A I i A A G C I g I J i K C E R K A c A A k w B E I m A e A w I A O I A A A A A A A A A B A A A A A A A A A A A A A A A A A A A = = |
Topological Polar Surface Area | 20.2 |
Monoisotopic Mass | 122.073 |
Exact Mass | 122.073 |
Compound Is Canonicalized | True |
Formal Charge | 0 |
Heavy Atom Count | 9 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Isotope Atom Count | 0 |
Covalently-Bonded Unit Count | 1 |
From Pubchem
Food Additives Biosynthesis/Degradation
ADMET Predicted Profile --- Classification
Model | Result | Probability |
---|---|---|
Absorption | ||
Blood-Brain Barrier | BBB+ | 0.8857 |
Human Intestinal Absorption | HIA+ | 0.9972 |
Caco-2 Permeability | Caco2+ | 0.9131 |
P-glycoprotein Substrate | Non-substrate | 0.7083 |
P-glycoprotein Inhibitor | Non-inhibitor | 0.9549 |
Non-inhibitor | 0.9754 | |
Renal Organic Cation Transporter | Non-inhibitor | 0.8893 |
Distribution | ||
Subcellular localization | Mitochondria | 0.7339 |
Metabolism | ||
CYP450 2C9 Substrate | Non-substrate | 0.7465 |
CYP450 2D6 Substrate | Non-substrate | 0.8717 |
CYP450 3A4 Substrate | Non-substrate | 0.7343 |
CYP450 1A2 Inhibitor | Inhibitor | 0.6966 |
CYP450 2C9 Inhibitor | Non-inhibitor | 0.8569 |
CYP450 2D6 Inhibitor | Non-inhibitor | 0.9623 |
CYP450 2C19 Inhibitor | Non-inhibitor | 0.7314 |
CYP450 3A4 Inhibitor | Non-inhibitor | 0.9220 |
CYP Inhibitory Promiscuity | Low CYP Inhibitory Promiscuity | 0.7336 |
Excretion | ||
Toxicity | ||
Human Ether-a-go-go-Related Gene Inhibition | Weak inhibitor | 0.7754 |
Non-inhibitor | 0.9461 | |
AMES Toxicity | Non AMES toxic | 0.9596 |
Carcinogens | Non-carcinogens | 0.6511 |
Fish Toxicity | High FHMT | 0.7855 |
Tetrahymena Pyriformis Toxicity | High TPT | 0.9718 |
Honey Bee Toxicity | High HBT | 0.8275 |
Biodegradation | Not ready biodegradable | 0.5230 |
Acute Oral Toxicity | III | 0.5860 |
Carcinogenicity (Three-class) | Non-required | 0.5882 |
From admetSAR
ADMET Predicted Profile --- Regression
Model | Value | Unit |
---|---|---|
Absorption | ||
Aqueous solubility | -1.3042 | LogS |
Caco-2 Permeability | 1.5541 | LogPapp, cm/s |
Distribution | ||
Metabolism | ||
Excretion | ||
Toxicity | ||
Rat Acute Toxicity | 2.2359 | LD50, mol/kg |
Fish Toxicity | 1.1418 | pLC50, mg/L |
Tetrahymena Pyriformis Toxicity | 0.1124 | pIGC50, ug/L |
From admetSAR
Toxicity Profile
Route of Exposure | Dermal ; inhalation ; oral |
---|---|
Mechanism of Toxicity | Metabolized to 1- and 2- phenylethanol . |
Metabolism | |
Toxicity Values | |
Lethal Dose | |
Carcinogenicity (IARC Classification) | No indication of carcinogenicity (not listed by IARC). |
Minimum Risk Level | |
Health Effects | Respiratory distress, cardiovascular collapse, shock, ventricular tachycardia, and coma in an adult. Liver, lung, central nervous system and renal injury may also occur (T36). |
Treatment | Consider activated charcoal. Monitor for respiratory distress in case of inhalation exposure. Irrigate exposed eyes with copious amounts of room temperature water for at least 15 minutes. |
Reference |
|
From T3DB
Taxonomic Classification
Kingdom | Organic compounds |
---|---|
Superclass | Benzenoids |
Class | Phenols |
Subclass | 1-hydroxy-2-unsubstituted benzenoids |
Intermediate Tree Nodes | Not available |
Direct Parent | 1-hydroxy-2-unsubstituted benzenoids |
Alternative Parents | |
Molecular Framework | Aromatic homomonocyclic compounds |
Substituents | 1-hydroxy-2-unsubstituted benzenoid - Monocyclic benzene moiety - Organic oxygen compound - Hydrocarbon derivative - Organooxygen compound - Aromatic homomonocyclic compound |
Description | This compound belongs to the class of organic compounds known as 1-hydroxy-2-unsubstituted benzenoids. These are phenols that a unsubstituted at the 2-position. |
From ClassyFire
Targets
- General Function:
- Zinc ion binding
- Specific Function:
- Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1.
- Gene Name:
- ESR1
- Uniprot ID:
- P03372
- Molecular Weight:
- 66215.45 Da
References
- Dang Z: Comparison of relative binding affinities to fish and mammalian estrogen receptors: the regulatory implications. Toxicol Lett. 2010 Feb 15;192(3):298-315. doi: 10.1016/j.toxlet.2009.11.004. Epub 2009 Nov 12. [19913605 ]
- General Function:
- Zinc ion binding
- Specific Function:
- Nuclear hormone receptor. Binds estrogens with an affinity similar to that of ESR1, and activates expression of reporter genes containing estrogen response elements (ERE) in an estrogen-dependent manner (PubMed:20074560). Isoform beta-cx lacks ligand binding ability and has no or only very low ere binding activity resulting in the loss of ligand-dependent transactivation ability. DNA-binding by ESR1 and ESR2 is rapidly lost at 37 degrees Celsius in the absence of ligand while in the presence of 17 beta-estradiol and 4-hydroxy-tamoxifen loss in DNA-binding at elevated temperature is more gradual.
- Gene Name:
- ESR2
- Uniprot ID:
- Q92731
- Molecular Weight:
- 59215.765 Da
References
- Dang Z: Comparison of relative binding affinities to fish and mammalian estrogen receptors: the regulatory implications. Toxicol Lett. 2010 Feb 15;192(3):298-315. doi: 10.1016/j.toxlet.2009.11.004. Epub 2009 Nov 12. [19913605 ]
From T3DB